Our results represent the first report regarding the relationship between the genetic polymorphisms of TYMS, MTHFR, ATIC, MTR, and MTRR related to the therapeutic outcome of MTX for RA in the Chinese population. The gene discussed is TYMS; the disease is rheumatoid arthritis.